Genetic Engineering in the Press by GEG

A new study led by scientists at Beth Israel Deaconess Medical Center shows than an HIV-1 vaccine regimen, involving a viral vector boosted with a purified envelope protein, provided complete protection in half of the vaccinated non-human primates (NHPs) against a series of six repeated challenges with simian immunodeficiency virus (SIV), a virus similar to HIV that infects NHPs.

www.geg-tech.com/Vectors